Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Payables (2023 - 2026)

Cannabis Bioscience International Holdings' Payables history spans 4 years, with the latest figure at $302188.0 for Q1 2026.

  • On a quarterly basis, Payables rose 95.63% to $302188.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $302188.0, a 95.63% increase, with the full-year FY2025 number at $109525.0, down 33.96% from a year prior.
  • Payables hit $302188.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from $159217.0 in the prior quarter.
  • Over the last five years, Payables for CBIH hit a ceiling of $364788.0 in Q4 2023 and a floor of $107660.0 in Q3 2025.
  • Historically, Payables has averaged $206973.3 across 4 years, with a median of $168355.0 in 2024.
  • Biggest five-year swings in Payables: tumbled 56.75% in 2025 and later surged 95.63% in 2026.
  • Tracing CBIH's Payables over 4 years: stood at $364788.0 in 2023, then crashed by 53.85% to $168355.0 in 2024, then fell by 5.43% to $159217.0 in 2025, then soared by 89.8% to $302188.0 in 2026.
  • Business Quant data shows Payables for CBIH at $302188.0 in Q1 2026, $159217.0 in Q4 2025, and $107660.0 in Q3 2025.